NO20071466L - 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE - Google Patents

3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE

Info

Publication number
NO20071466L
NO20071466L NO20071466A NO20071466A NO20071466L NO 20071466 L NO20071466 L NO 20071466L NO 20071466 A NO20071466 A NO 20071466A NO 20071466 A NO20071466 A NO 20071466A NO 20071466 L NO20071466 L NO 20071466L
Authority
NO
Norway
Prior art keywords
inhibitors
formula
substituted
casein kinase
carboxylic acid
Prior art date
Application number
NO20071466A
Other languages
English (en)
Inventor
Jr William Arthur Metz
Fa-Xiang Ding
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20071466L publication Critical patent/NO20071466L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det beskrives forbindelser med formel (I) og formel (II) som inhibitorer av human kasein kinase le og metoder for å benytte forbindelsene med formel (I) og formel (II) for behandling av sentralnervesystemsykdommer og forstyrrelser inkludert stemningsforstyrrelser og søvnforstyrrelser. Det beskrives videre farmasøytiske preparater omfattende forbindelser med formel (I) og formel (II).
NO20071466A 2004-08-19 2007-03-19 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE NO20071466L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60338004P 2004-08-19 2004-08-19
PCT/US2005/029053 WO2006023467A1 (en) 2004-08-19 2005-08-16 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Iϵ

Publications (1)

Publication Number Publication Date
NO20071466L true NO20071466L (no) 2007-04-19

Family

ID=35311279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071466A NO20071466L (no) 2004-08-19 2007-03-19 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE

Country Status (26)

Country Link
US (2) US7629376B2 (no)
EP (1) EP1794122B1 (no)
JP (1) JP4843608B2 (no)
KR (2) KR20070043012A (no)
CN (1) CN101006055B (no)
AR (1) AR050919A1 (no)
AT (1) ATE508112T1 (no)
AU (1) AU2005277523B2 (no)
BR (1) BRPI0514380A (no)
CA (1) CA2577667C (no)
DE (1) DE602005027858D1 (no)
GT (1) GT200500214A (no)
IL (1) IL181156A (no)
JO (1) JO2724B1 (no)
MA (1) MA28863B1 (no)
MX (1) MX2007001382A (no)
NO (1) NO20071466L (no)
NZ (1) NZ552800A (no)
PA (1) PA8642901A1 (no)
PE (1) PE20060498A1 (no)
RU (1) RU2369599C2 (no)
SV (1) SV2006002192A (no)
TW (1) TWI357897B (no)
UY (1) UY29078A1 (no)
WO (1) WO2006023467A1 (no)
ZA (1) ZA200700651B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4748823B2 (ja) 2009-02-12 2011-08-17 株式会社ファルマデザイン カゼインキナーゼ１δ及びカゼインキナーゼ１ε阻害剤
BRPI1016185A2 (pt) * 2009-04-17 2016-04-19 Cylene Pharmaceuticals Inc processo para o tratamento de distúrbios associados à atividade da proteína quinase ck2
AU2013283318B2 (en) 2012-06-27 2017-11-23 4Sc Ag Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders
JP2021511364A (ja) 2018-01-29 2021-05-06 カディラ ヘルスケア リミティド 抗菌剤として有用な複素環式化合物
WO2022006377A2 (en) * 2020-07-02 2022-01-06 Mbq Pharma Heterocyclic inhibitors of rho gtpases for the treatment of disease
US12209078B2 (en) 2021-10-06 2025-01-28 Mbq Pharma Crystalline forms of carbazole inhibitors of RhoGTPase for the treatment of disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296471A (en) 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
DE60026998T2 (de) * 1999-06-08 2007-04-05 Aventis Pharmaceuticals Inc. Screeningsverfahren zur änderung zirkadiane-rhythmus-eiweisse
CN1249051C (zh) * 2000-04-28 2006-04-05 阿卡蒂亚药品公司 毒蕈碱性激动剂
WO2004014851A2 (en) * 2002-08-09 2004-02-19 Merck & Co., Inc. Tyrosine kinase inhibitors
DE602004020685D1 (de) * 2003-12-11 2009-05-28 Aventis Pharma Inc Substituierte 1h-pyrroloä3,2-b, 3,2-c und 2,3-cüpyridin-2-carbonsäureamide und verwandte analoga als inhibitoren von caseinkinase-i-epsilon

Also Published As

Publication number Publication date
BRPI0514380A (pt) 2008-06-10
EP1794122A1 (en) 2007-06-13
PE20060498A1 (es) 2006-07-10
MA28863B1 (fr) 2007-09-03
TW200621711A (en) 2006-07-01
CN101006055A (zh) 2007-07-25
TWI357897B (en) 2012-02-11
AU2005277523B2 (en) 2011-09-29
SV2006002192A (es) 2006-06-28
CN101006055B (zh) 2011-06-22
US20080027124A1 (en) 2008-01-31
DE602005027858D1 (de) 2011-06-16
RU2369599C2 (ru) 2009-10-10
CA2577667A1 (en) 2006-03-02
RU2007109783A (ru) 2008-09-27
EP1794122B1 (en) 2011-05-04
IL181156A (en) 2011-09-27
PA8642901A1 (es) 2006-05-16
JP4843608B2 (ja) 2011-12-21
ZA200700651B (en) 2008-09-25
WO2006023467A1 (en) 2006-03-02
ATE508112T1 (de) 2011-05-15
JO2724B1 (en) 2013-09-15
KR20070043012A (ko) 2007-04-24
NZ552800A (en) 2010-11-26
US20090082340A1 (en) 2009-03-26
US7629376B2 (en) 2009-12-08
AR050919A1 (es) 2006-12-06
AU2005277523A1 (en) 2006-03-02
JP2008510017A (ja) 2008-04-03
CA2577667C (en) 2011-01-04
GT200500214A (es) 2006-03-27
MX2007001382A (es) 2007-04-19
UY29078A1 (es) 2006-03-31
US7923466B2 (en) 2011-04-12
KR20130038409A (ko) 2013-04-17
IL181156A0 (en) 2007-07-04
HK1105196A1 (en) 2008-02-06

Similar Documents

Publication Publication Date Title
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20050828L (no) lndol-3-svovelderivater
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
NO20072567L (no) Triazoler nyttige som proteinkinase-inhibitorer
IL188942A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
MA28279A1 (fr) Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20070502L (no) Azaindoler nyttige som inhibitorer av proteinkinaser
NO20071466L (no) 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE
JO2629B1 (en) Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
UA94054C2 (en) Nitrocatechol derivatives as comt inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application